Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

coronavirus

  • Home
  •  
  • coronavirus



  • Most Read
  • Latest Comments
  • Harris Tech report $1m revenue from opportunistic sanitary sales
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Harris Tech report $1m revenue from opportunistic sanitary sales
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Harris Tech report $1m revenue from opportunistic sanitary sales
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Harris Tech report $1m revenue from opportunistic sanitary sales
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Harris Tech report $1m revenue from opportunistic sanitary sales
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians
    Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians
    • News

  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium
    Harris Technology secures major investment from Taiwan's FSP Technology at 100% premium
    • News

  • Harris Technology nears profitability as refurbished tech division gains traction
    Harris Technology nears profitability as refurbished tech division gains traction
    • News

  • Harris Technology sees big opportunity for refurbished tech in 2025 with positive cash flow
    Harris Technology sees big opportunity for refurbished tech in 2025 with positive cash flow
    • News

  • Harris Technology continues growth with refurbished tech sales surpassing second $1M in just three months
    Harris Technology continues growth with refurbished tech sales surpassing second $1M in just three months
    • News

  • Harris Tech report $1m revenue from opportunistic sanitary sales
    • News

    Harris Tech report $1m revenue from opportunistic sanitary sales

    When Harris Technology (ASX: HT8) started selling sanitary products amidst the global demand surge brought upon by the coronavirus pandemic, they estimated Q4 sales of around $400,000. Today they reported they have sold more than $1 million worth of their Pro-Hygiene products in April alone. Whilst IT and electronics are Harris Technology’s flagship products, they

    Read More
    Public
  • ‘Don’t fight the Fed’ – Macro update
    • Opinion

    ‘Don’t fight the Fed’ – Macro update

    “Don’t fight the Fed” as you are being paid to take risks. Your investment thesis on asset classes at this present moment will be to follow the Fed (or central bank) dollar. Moral hazard is too costly it seems, and the latest unprecedented stimulus measures announced by the U.S. Fed in corporate credit markets highlights that the “whatever

    Read More
    Public
  • With 400 million glove backlog, VIP Gloves sold out till December 2020
    • News

    With 400 million glove backlog, VIP Gloves sold out till December 2020

    Shares in the lightly traded gloves manufacturer VIP Gloves (ASX: VIP) have skyrocketed this morning on news that the Company has such a large backlog of orders that their 24/7 production capacity is fully committed until December 2020.  With their production facilities based in Malaysia and not impacted by the Malaysian Government’s COVID-19 biosecurity measures,

    Read More
    Public
  • 1st Group launches telehealth portal, telehealthclinics.com.au
    • News

    1st Group launches telehealth portal, telehealthclinics.com.au

    Already facilitating 2 million medical appointments between medical professionals and patients, health tech company 1st Group (ASX: 1ST) is set to significantly grow its network with the launch of telehealthclinics.com.au – a dedicated site for booking medical appointments to be conducted via teleconference.  Whilst COVID-19 has significantly heightened public interest in telehealth, 1st Group has

    Read More
    Public
  • FDA grants Prizma over-the-counter authorisation, G Medical shares surge 200%
    • News

    FDA grants Prizma over-the-counter authorisation, G Medical shares surge 200%

    As the world battles the coronavirus pandemic, G Medical (ASX: GMV) has secured authorisation from the Food and Drug Administration to sell their Prizma smartphone attachment direct to customers without the need for a prescription, rocketing the company’s share price.  Prizma, a smartphone attachment which can monitor a user’s vital signs, can play a vital

    Read More
    Public
  • Coronavirus has the retail sector on life support, but death is inevitable
    • Opinion

    Coronavirus has the retail sector on life support, but death is inevitable

    As an industry which had already been fighting for survival before the coronavirus pandemic, the stark reality is that the retail sector will never recover from the fallout of COVID-19.  Walking through the corridors of Highpoint Shopping Centre during normal trading hours, more than 80% of retail stores had shut their doors, the only ones

    Read More
    Public
  • 1
  • 2
  • 3
  • 4
  • 5

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.